NASDAQ: PCVX · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Vaxcyte Inc.

How Vaxcyte Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$9.9B

Price

$62.61

P/E

-8.5

EPS (TTM)

$-7.35

1-year return

43.9%

Dividend yield

0.0%

52-week range

$47.67–$71.38

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources